Observational studyInternational ophthalmology2025
Evaluation of optical coherence tomography angiography role in differentiating ischemic and non-ischemic central retinal vein occlusion.
Observational study in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the role of optical coherence tomography angiography (OCTA) in differentiating ischemic and non-ischemic central retinal vein occlusion (CRVO).
methodsThis prospective observational study included 72 eyes with CRVO (36 ischemic, 36 non-ischemic), all presenting with macular edema. Participants underwent clinical evaluation, fundus fluorescein angiography (FFA), and OCTA imaging. Key parameters analyzed included vessel density (VD) in the superficial and deep capillary plexuses (SCP and DCP), central retinal thickness (CRT), foveal avascular zone (FAZ) area, perimeter (PERIM), and flow density within 300 μm of the FAZ (FD-300).
resultsIschemic CRVO eyes showed significantly lower superficial VD (45.13 ± 1.98 vs. 46.45 ± 3.42; p = 0.048), thinner CRT (390.53 ± 193.66 vs. 538.14 ± 139.63; p = 0.001), larger FAZ area (0.442 ± 0.239 vs. 0.245 ± 0.129; p = 0.001), and higher PERIM (2.82 ± 0.72 vs. 1.95 ± 0.56; p = 0.001) compared to non-ischemic eyes. FAZ (AUC = 0.769; sensitivity = 91.7%, specificity = 58.3%) and PERIM (AUC = 0.819; sensitivity = 88.9%, specificity = 66.7%) demonstrated strong diagnostic performance. Regression analysis identified age, intraocular pressure (IOP), CRT, FAZ, PERIM, and FD-300 as significant predictors of ischemia.
conclusionsOCTA is a valuable, noninvasive tool for differentiating ischemic from non-ischemic CRVO based on quantitative microvascular parameters, with FAZ area and PERIM offering particularly strong diagnostic utility.
Indexed as
Identifiers
40911087What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.